Streetbeat News

Analyst Ratings

RVNC

Analysts have provided bullish ratings for Revance Therapeutics (NASDAQ:RVNC) in the last quarter. The average price target is $34.33, implying an upside from the current price of $13.81. However, this represents an 8.04% decrease from the previous average price target of $37.33.

Portfolio Pulse from Benzinga Insights

September 20, 2023 | 12:00 pm

EOG

Citigroup analyst Scott Gruber maintains a Buy rating on EOG Resources (NYSE:EOG) and raises the price target from $138 to $144.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 12:00 pm

DVN

Citigroup analyst Scott Gruber has maintained a 'Buy' rating on Devon Energy (NYSE:DVN) but lowered the price target from $57 to $55.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 11:59 am

CTRA

Citigroup analyst Scott Gruber has maintained a Neutral rating on Coterra Energy (NYSE:CTRA) and raised the price target from $26 to $27.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 11:58 am

NKE

Citigroup analyst Paul Lejuez has maintained a Neutral rating on Nike (NYSE:NKE) and lowered the price target from $109 to $100.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 11:55 am

STZ

JP Morgan analyst Andrea Teixeira maintains an Overweight rating on Constellation Brands (NYSE:STZ) and raises the price target from $276 to $307.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 11:54 am

PINS

Wells Fargo analyst Ken Gawrelski has maintained an 'Overweight' rating on Pinterest (NYSE:PINS) but lowered the price target from $36 to $35.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 11:52 am

LEN

JP Morgan analyst Michael Rehaut maintains a Neutral rating on Lennar (NYSE:LEN) and lowers the price target from $136 to $135.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 11:51 am

AZO

JP Morgan analyst Christopher Horvers maintains an Overweight rating on AutoZone (NYSE:AZO) and raises the price target from $2950 to $2975.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 11:50 am

AMAM

FYBR

WEST

Insider trades were noted in Westrock Coffee Company (NASDAQ:WEST), Ambrx Biopharma Inc. (NASDAQ:AMAM), and Frontier Communications Parent, Inc. (NASDAQ:FYBR). Westrock's Director acquired shares worth around $18.77 million, despite the company posting downbeat Q2 results. Ambrx's 10% owner acquired shares worth around $19.63 million, following Cantor Fitzgerald's reiteration of an Overweight rating and a $25 price target. Ares Partners Holdco LLC, a 10% owner of Frontier Communications, bought shares worth around $1.48 million, even as JP Morgan lowered the price target from $35 to $33.

Portfolio Pulse from Lisa Levin

September 20, 2023 | 11:50 am